Mounjaro
drug0.0Global Dominance: 0.00%
Mounjaro is a brand name for the medication tirzepatide, developed by Eli Lilly. It is an injectable medication used for the treatment of type 2 diabetes and has gained attention for its effectiveness in lowering blood sugar levels and promoting weight loss, making it a popular choice among patients.
Power0
Reach0
Collect
Not in the pool (under ¢1).
Recent news mentions
Mounjaro is a popular injectable drug that Eli Lilly's Orforglipron is compared to.
Eli Lilly corre a Wall Street grazie alla pillola anti-obesità e diabete in fase di studio (che sostituirà le iniezioni)Corriere della Sera·
Italy· 2025-04-17
Italy· 2025-04-17
